Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionRossmore Private Capital
Latest Disclosed Ownership4,782 shares
Latest Disclosed Value $ 666,467
Rossmore Private Capital ownership in GILD / Gilead Sciences, Inc.

On May 1, 2026 - Rossmore Private Capital filed a 13F-HR form disclosing ownership of 4,782 shares of Gilead Sciences, Inc. (CH:GILD) valued at $666,467 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 4,182 shares of Gilead Sciences, Inc.. This represents a change in shares of 14.35% during the quarter.

Rossmore Private Capital has a history of taking positions in derivatives of the underlying security (GILD) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CH:GILD / Gilead Sciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F GILEAD SCIENCES COM 375558103 4,782 600 14.35 666 29.82 0.0585
2026-02-05 2025-12-31 13F GILEAD SCIENCES COM 375558103 4,182 200 5.02 513 16.06 0.0457
2025-10-30 2025-09-30 13F GILEAD SCIENCES COM 375558103 3,982 0 0.00 442 0.23 0.0476
2025-08-07 2025-06-30 13F GILEAD SCIENCES COM 375558103 3,982 3,982 441 0.0515
2024-08-12 2024-06-30 13F GILEAD SCIENCES COM 375558103 0 -5,686 -100.00 0 -100.00
2024-05-13 2024-03-31 13F GILEAD SCIENCES COM 375558103 5,686 -100 -1.73 416 -11.11 0.0545
2024-02-07 2023-12-31 13F GILEAD SCIENCES COM 375558103 5,786 25 0.43 469 8.58 0.0662
2023-11-13 2023-09-30 13F GILEAD SCIENCES COM 375558103 5,761 -300 -4.95 432 -7.71 0.0654
2023-08-14 2023-06-30 13F GILEAD SCIENCES COM 375558103 6,061 -2,000 -24.81 467 -30.09 0.0695
2023-05-02 2023-03-31 13F GILEAD SCIENCES COM 375558103 8,061 0 0.00 669 -3.47 0.1045
2023-02-14 2022-12-31 13F GILEAD SCIENCES COM 375558103 8,061 332 4.30 692 0.1108
2022-11-08 2022-09-30 13F GILEAD SCIENCES COM 375558103 7,729 0 0.00 0 0.0854
2022-08-11 2022-06-30 13F GILEAD SCIENCES COM 375558103 7,729 400 5.46 0 0.0828
2022-05-09 2022-03-31 13F GILEAD SCIENCES COM 375558103 7,329 -350 -4.56 0 0.0679
2022-02-07 2021-12-31 13F GILEAD SCIENCES COM 375558103 7,679 0 0.00 1 0.0871
2021-11-08 2021-09-30 13F GILEAD SCIENCES COM 375558103 7,679 -1,000 -11.52 1 0.0918
2021-08-13 2021-06-30 13F GILEAD SCIENCES COM 375558103 8,679 0 0.00 1 0.1023
2021-05-10 2021-03-31 13F GILEAD SCIENCES COM 375558103 8,679 955 12.36 1 0.1052
2021-02-10 2020-12-31 13F GILEAD SCIENCES COM 375558103 7,724 3,262 73.11 0 0.0912
2020-11-10 2020-09-30 13F GILEAD SCIENCES COM 375558103 4,462 26 0.59 0 -100.00 0.0663
2020-08-05 2020-06-30 13F GILEAD SCIENCES COM 375558103 4,436 4,436 341 0.0942
2018-05-04 2018-03-31 13F GILEAD SCIENCES COM 375558103 0 -900 -100.00 0 -100.00
2018-03-15 2017-12-31 13F GILEAD SCIENCES COM 375558103 900 900 64 0.0650
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-01 2026-03-31 13F GILEAD SCIENCES COM Put 2,800 16.67 390 32.65 n/a n/a n/a
2026-02-05 2025-12-31 13F GILEAD SCIENCES COM Put 2,400 295 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.